Comerica Bank Decreases Stock Holdings in Waystar Holding Corp. $WAY

Comerica Bank trimmed its stake in shares of Waystar Holding Corp. (NASDAQ:WAY) by 55.3% in the 4th quarter, Holdings Channel reports. The firm owned 25,375 shares of the company’s stock after selling 31,369 shares during the period. Comerica Bank’s holdings in Waystar were worth $831,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in WAY. Royal Bank of Canada raised its holdings in shares of Waystar by 11.3% during the first quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after purchasing an additional 2,195 shares during the last quarter. AQR Capital Management LLC purchased a new position in shares of Waystar during the first quarter valued at approximately $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Waystar by 91.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after buying an additional 22,364 shares during the last quarter. NewEdge Advisors LLC purchased a new stake in Waystar during the first quarter valued at approximately $234,000. Finally, Goldman Sachs Group Inc. increased its holdings in Waystar by 13.4% during the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock valued at $27,918,000 after buying an additional 88,256 shares during the last quarter.

Analysts Set New Price Targets

A number of analysts have commented on WAY shares. Wall Street Zen cut shares of Waystar from a “buy” rating to a “hold” rating in a report on Saturday, February 21st. Morgan Stanley started coverage on shares of Waystar in a report on Monday, March 30th. They set an “equal weight” rating and a $28.00 target price for the company. BMO Capital Markets reduced their target price on shares of Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, February 18th. JPMorgan Chase & Co. reduced their target price on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Finally, Mizuho set a $42.00 target price on shares of Waystar in a report on Wednesday, February 4th. Three investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $36.14.

Waystar Stock Performance

WAY opened at $21.38 on Monday. The firm has a market cap of $4.10 billion, a P/E ratio of 31.91, a PEG ratio of 0.85 and a beta of 0.21. Waystar Holding Corp. has a 1-year low of $19.78 and a 1-year high of $42.55. The company has a 50 day simple moving average of $24.30 and a two-hundred day simple moving average of $29.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76.

Waystar (NASDAQ:WAY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The company’s revenue was up 22.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Equities analysts forecast that Waystar Holding Corp. will post 1.45 earnings per share for the current fiscal year.

Waystar Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.